market access, drug value, healthcare, evidence, ebook, market access usa

Download ebook: Essential Insights on demonstrating drug value in a challenging market

    How are pharma, payers and patients utilizing evidence of real world outcomes to better understand and demonstrate drug value and improve patient care? How is the global market access environment changing and how is this impacting on pharmaceutical organisations? What does pharma need to know about the diverse payer landscape, alternative payment plans and communicating and influencing decision making? These are some important questions …

5 ways digital technology is impacting health

In a recent survey launched by Total Biopharma, leading pharmaceutical and biotech executives were asked to rate the areas of healthcare which they felt would be most significantly impacted by the emergence of digital health. From a long list which included clinical trial management, medical adherence and health education, these were the most highly rated areas of healthcare which set …

Moving Towards Personalised Medicine with Big Data Strategies

  The use of Big Data strategies is thought to have the potential to help physicians and scientists move closer to treating individuals, rather than diseases. Developing treatments that are tailored to an individual’s history and sensitivities presents many challenges, and will only be possible within a digital health care system. An article from 20 January 2011 in the U.S. News & World …

intel smartwatch parkinsons

Intel Develops Big Data Tools and Wearables to Diagnose and Study Parkinson’s

Intel has announced a partnership with the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to develop Big Data tools that will hopefully help diagnose this degenerative disorder earlier, and find a cure. Wearable sensors under the form of smartwatches could be the biggest progress of the last 200 years in terms of assessment tools available to diagnose and study …

Download: Risk Based Pricing in Healthcare: current practice and future prospects

  Last year's Pharma Pricing & Market Access Europe 2013, key topics discussed included maneuvering changes in the healthcare environment, pricing & market access in the major international markets and patient access and flexible pricing schemes. At last year’s event, a notable presentation was given by Allen King, Global Pricing Leader at Optum, entitled on risk based pricing in healthcare: …

Download ebook: Top challenges in HTA

    In today's austere times, payers are continuing to control escalating healthcare costs, relying on health technology assessment agencies in order to make purchasing decisions and effective use of funds.  HTA is an important part of evidence-based health decision-making in most EU countries with ever increasing demands for value demonstration proving your drugs are most beneficial to patients. This …

Download: The growth of HTA- Implications for the industry

  According to a recent article on PMlive, "while harmonised regulatory approval processes have created synergies that decrease the workload of European payers and institutional stakeholders, the same may not be said for the case of health technology assessment (HTA)." With a diverse range of country specific HTA processes for new drug entrants, the growth of HTA across European healthcare …

Download ebook: 7 drugs that will need to provide further Evidence

With every new, approved drug comes payer expectations. To make sure that pharma meet the needs of this healthcare customer base it is critical that they demonstrate the value in their new products against the treatment standard. What follows is a listing of 7 new, exciting therapeutic agents which are facing challenges in the present US healthcare environment, and whose …

Making healthcare affordable in India

Both the private and public healthcare industry in India is seeing increasing government funding, higher patient care standards and better access of patients to necessary treatments. Still, the provision of healthcare services in India is skewed towards urban residents. According to a study by IMS Health, urban residents constitute about 28 percent of India's population but have access to two …